Nemes Rush Group’s ResMed RMD Stock Holding History

Nemes Rush Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.25K	Hold	10	–	–	﹤0.01%	729
2025 Q4	$2.41K	Buy	+10	New	+$2.56K	﹤0.01%	708

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nemes Rush Group's RMD Position: Q1 2026 in Review

Nemes Rush Group held its ResMed (RMD) position steady in Q1 2026 at 10 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Nemes Rush Group first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.41K in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Nemes Rush Group held 10 shares of ResMed worth $2.25K as of Q1 2026.
Nemes Rush Group left its ResMed share count unchanged in Q1 2026.
ResMed made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #729 holding.
Nemes Rush Group first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
Nemes Rush Group's ResMed position peaked at $2.41K in Q4 2025.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.